PTEN and neoplasm: Indeed, PD-L1 expression in radical prostatectomy-derived prostate tumours is rare.114 Collectively, these observations demonstrate that knowledge of the status of PTEN might be useful in deciding which patients and which specific tumour types might benefit from current immunotherapeutic approaches.